Intercalated cell BKα subunit is required for flow-induced K+ secretion.

JCI insight (2020-04-08)
Rolando Carrisoza-Gaytan, Evan C Ray, Daniel Flores, Allison L Marciszyn, Peng Wu, Leah Liu, Arohan R Subramanya, WenHui Wang, Shaohu Sheng, Lubika J Nkashama, Jingxin Chen, Edwin K Jackson, Stephanie M Mutchler, Szilvia Heja, Donald E Kohan, Lisa M Satlin, Thomas R Kleyman

BK channels are expressed in intercalated cells (ICs) and principal cells (PCs) in the cortical collecting duct (CCD) of the mammalian kidney and have been proposed to be responsible for flow-induced K+ secretion (FIKS) and K+ adaptation. To examine the IC-specific role of BK channels, we generated a mouse with targeted disruption of the pore-forming BK α subunit (BKα) in ICs (IC-BKα-KO). Whole cell charybdotoxin-sensitive (ChTX-sensitive) K+ currents were readily detected in control ICs but largely absent in ICs of IC-BKα-KO mice. When placed on a high K+ (HK) diet for 13 days, blood [K+] was significantly greater in IC-BKα-KO mice versus controls in males only, although urinary K+ excretion rates following isotonic volume expansion were similar in males and females. FIKS was present in microperfused CCDs isolated from controls but was absent in IC-BKα-KO CCDs of both sexes. Also, flow-stimulated epithelial Na+ channel-mediated (ENaC-mediated) Na+ absorption was greater in CCDs from female IC-BKα-KO mice than in CCDs from males. Our results confirm a critical role of IC BK channels in FIKS. Sex contributes to the capacity for adaptation to a HK diet in IC-BKα-KO mice.

Referencia del producto
Descripción del producto

Aldosterone, ≥95% (HPLC)
Benzamil hydrochloride hydrate, ≥98% (HPLC)
FURA 2/AM in Solution - CAS 108964-32-5 - Calbiochem

Redes sociales

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Investigación. Desarrollo. Producción.

Somos un proveedor líder para la industria de Ciencias de la Vida con soluciones y servicios para investigación, desarrollo y producción biotecnológicos, y para desarrollo y producción de tratamientos farmacéuticos

© 2021 Merck KGaA, Darmstadt, Alemania y/o sus filiales. Todos los derechos reservados.

Queda estrictamente prohibida la reproducción sin permiso de cualquiera de los materiales de la página web.